Benchling is a biology-first platform for scientific data, collaboration, and insights, dedicated to accelerating R&D and driving impact in the biotech industry.

Cory Li

Ashutosh Singhal

Sajith Wickramasekara

Benchling

Appsilon is a software development and data innovation partner, providing tailored solutions in data science and software engineering, primarily for the biotech and pharmaceutical sectors.

Appsilon

DVLP is building a new infrastructure for drug development by digitizing drug assets, financing, and development workflows to accelerate the process of turning molecules into medicines.

DVLP

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Metric
Company Name	Benchling	Appsilon	DVLP	Ginkgo Bioworks Holdings, Inc.
Symbol				DNA
MSH ID	COM:BENCHLING	COM:APPSILON	COM:DVLPMEDICINES	COM:GINKGOBIOWORKS
Market	PRIVATE	PRIVATE	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Technology	Healthcare & Health Services	Healthcare
Industry	Biotechnology	Software & IT Services	Pharmaceuticals	Biotechnology
Country		PL	US	US
Stage				Grant
Employee Count	501			1.22K
Website	benchling.com	appsilon.com	dvlpmedicines.com	ginkgobioworks.com
LinkedIn			dvlpmedicines	ginkgo-bioworks
Founders

Metric
Market Cap		725.64M
Enterprise Value
Monthly Web Traffic	133	20.69K
Web Traffic Growth	-0.55	-0.17
Valuation
Raised Capital

Metric
Revenue				251.46M
Revenue (LTM)
Revenue (NTM)
Gross Profit				142.64M
EBITDA				-600.68M
Operating Income				-672.23M
Net Income				-892.87M
EPS				-0.46
Diluted EPS				-0.46
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin				0.75
Operating Profit Margin				-3.34
EBITDA Margin				-2.39
Net Profit Margin				-3.55
Return on Equity				-0.65
Return on Assets				-0.54
Return on Capital Employed				-0.51

BENC

COM:BENCHLING

Benchling

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio				-2.78
P/B Ratio				1.90
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio				93.70
EV Multiple				-1.34

Metric
Days Sales Outstanding				73.17
Days Payables Outstanding				50.57
Days Inventory Outstanding				0.27
Operating Cycle				46.33
Cash Conversion Cycle				-7.39
Asset Turnover				0.15

Metric
Operating Cash Flow				-295.50M
Free Cash Flow				-336.30M
Cash Flow to Debt				-0.63
Operating Cash Flow/Sales				-1.14
Free Cash Flow Yield				-0.16

Metric
Cash & Equivalents				948.86M
Accounts Receivable				50.07M
Inventory				46K
Goodwill				49.24M
Debt to Capitalization				0.35
Debt to Assets				0.20
Current Ratio				6.78
Quick Ratio				5.98

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue				0.94
R&D to Revenue				2.05
SG&A to Revenue				1.32